초록 ▼

Implantable devices for controlled delivery of a drug are provided which include a substrate; at least two reservoirs in the substrate, each reservoir having an opening; at least one therapeutic agent in each of the reservoirs; a reservoir cap sealing each opening; a mechanical rupturing mechanism w

Implantable devices for controlled delivery of a drug are provided which include a substrate; at least two reservoirs in the substrate, each reservoir having an opening; at least one therapeutic agent in each of the reservoirs; a reservoir cap sealing each opening; a mechanical rupturing mechanism which moves into contact with and ruptures the reservoir cap to permit release the therapeutic agent from the reservoir through the opening; and a mixing chamber adjacent the reservoirs, wherein upon release of the therapeutic agent from at least one of the reservoirs, the therapeutic agent is combined with a carrier fluid in the mixing chamber and then transported to a delivery site in a human or animal.

대표청구항 ▼

I claim: 1. An implantable device for controlled delivery of a drug comprising: a substrate; at least two reservoirs in the substrate, each reservoir having an opening; at least one therapeutic agent in each of the reservoirs; a reservoir cap sealing each opening; a mechanical rupturing mechanism

I claim: 1. An implantable device for controlled delivery of a drug comprising: a substrate; at least two reservoirs in the substrate, each reservoir having an opening; at least one therapeutic agent in each of the reservoirs; a reservoir cap sealing each opening; a mechanical rupturing mechanism which comprises a structure which moves, at the time selected for rupture of a reservoir cap, from a non-contacting position outside of the reservoir into contact with and ruptures the reservoir cap to permit release of the therapeutic agent from the reservoir through the opening; and a mixing chamber adjacent the reservoirs, wherein upon release of the therapeutic agent from at least one of the reservoirs, the therapeutic agent is combined with a carrier fluid in the mixing chamber and then transported to a delivery site in a human or animal. 2. The device of claim 1, wherein the mechanical rupturing mechanism comprises an array of cantilevers adapted to forcefully contact the surface of the reservoir cap to rupture the reservoir cap. 3. The device of claim 1, wherein the reservoir cap comprises a thin film formed of a metal, a polymer, or a combination thereof. 4. The device of claim 1, wherein the therapeutic agent is in a matrix formed of degradable material or a material which releases the therapeutic agent by diffusion out of or disintegration of the matrix. 5. The device of claim 4, wherein the matrix comprises a polymer is selected from the group consisting of polyamides, polyesters, polyanhydrides, polyorthoesters, and polycarbonates. 6. The device of claim 1, wherein the carrier fluid comprises a natural biological fluid. 7. The device of claim 1, wherein the therapeutic agent is transported to the delivery site by concentration gradient driven diffusion. 8. The device of claim 1, wherein the therapeutic agent is a protein. 9. The device of claim 1, wherein the therapeutic agent is a hormone. 10. The device of claim 1, wherein the therapeutic agent is a nucleic acid. 11. A method of delivering a drug to a human or animal patient in need thereof comprising: implanting in the patient a device which comprises a substrate, at least two reservoirs in the substrate, each reservoir having an opening, at least one therapeutic agent in each of the reservoirs, a reservoir cap sealing each opening, and a mixing chamber adjacent the reservoirs; and activating a mechanical rupturing mechanism which comprises a structure which moves from a non-contacting position outside of the reservoir into contact with the reservoir cap, rupturing the reservoir cap to permit release of the therapeutic agent from the reservoir through the opening such that the therapeutic agent combines with a carrier fluid in the mixing chamber and then is transported to a delivery site in the patient. 12. The method of claim 11, wherein the cater fluid is a natural biological fluid and the therapeutic agent is transported to the delivery site by concentration gradient driven diffusion. 13. The method of claim 11, wherein the mechanical rupturing mechanism comprises an array of cantilevers adapted to forcefully contact the surface of the reservoir cap to rupture the reservoir cap. 14. The method of claim 11, wherein the reservoir cap comprises a thin film formed of a metal, a polymer) or a combination thereof.